Our medicines Our science Our stories
Contact us Careers
Americas

Argentina

Spanish

Brazil

Portuguese

Canada

English French

Chile

Spanish

Colombia

Spanish

Mexico

Spanish

Peru

Spanish

United States

English
Asia Pacific

Australia

English

China

Simplified Chinese

India

English

Japan

Japanese

Korea

Korean

New Zealand

English

Singapore

English

Taiwan

Traditional Chinese

Thailand

English Thai
Europe

Austria

German

Belgium

English Dutch French

Czech Republic

Czech

Denmark

Danish

Finland

Finnish

France

French

Germany

German

Greece

Greek

Hungary

Hungarian

Ireland

English

Italy

Italian

Luxembourg

English

Netherlands

English Dutch

Norway

Norwegian

Poland

Polish

Portugal

Portuguese

Romania

Romanian

Spain

Spanish

Sweden

Swedish

Switzerland

German French

United Kingdom

English
Middle East

Israel

Hebrew

Saudi Arabia

English Arabic

Turkey

Turkish

United Arab Emirates

English Arabic
Other

Other Markets

Distributor Markets
bmsUScqPageLucene
Medicines > Careers > Press Releases > Medical Information >
Our Medicines

Science

Learn more about our science, the core of our work.

Our multiple myeloma story: Collaboration drives progress
Advancing oncology care: The potential of subcutaneous immunotherapy
Advancing oncology care: The potential of subcutaneous immunotherapy
Advancing cell therapy: Shaping our approach today to reach more patients tomorrow
What's the future of cell therapy at BMS?




Subscribe to Our stories alerts
 

Beyond just relevant information about Bristol Myers Squibb's therapeutic areas and innovation, Our stories offer a window into the work our employees do every day for patients.